We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDY icon
1151
Teledyne Technologies
TDY
$29.2B
$102K ﹤0.01%
329
+91
+38% +$29.9K
PDCO
1152
DELISTED
Patterson Companies, Inc.
PDCO
$102K ﹤0.01%
4,663
-14,218
-75% -$249K
MATX icon
1153
Matsons
MATX
$6.11B
$101K ﹤0.01%
3,505
+308
+10% +$8.85K
LOGM
1154
DELISTED
LogMein, Inc.
LOGM
$101K ﹤0.01%
1,219
-1,862
-60% -$158K
AU icon
1155
AngloGold Ashanti
AU
$39.4B
$100K ﹤0.01%
3,403
-624
-15% -$15.4K
EIS icon
1156
iShares MSCI Israel ETF
EIS
$863M
$100K ﹤0.01%
1,931
-1,700
-47% -$85.5K
QGEN icon
1157
Qiagen
QGEN
$8.62B
$100K ﹤0.01%
2,225
-305
-12% -$13.7K
DXCM icon
1158
DexCom
DXCM
$29B
$99K ﹤0.01%
992
+764
+335% +$68.3K
TUP
1159
DELISTED
Tupperware Brands Corporation
TUP
$99K ﹤0.01%
20,977
+132
+0.6% +$439
GNRC icon
1160
Generac Holdings
GNRC
$11.5B
$98K ﹤0.01%
805
-5,664
-88% -$596K
GT icon
1161
Goodyear
GT
$2.09B
$98K ﹤0.01%
11,042
+249
+2% +$1.89K
SCHG icon
1162
Schwab US Large-Cap Growth ETF
SCHG
$58.2B
$98K ﹤0.01%
7,744
CNQ icon
1163
Canadian Natural Resources
CNQ
$96.9B
$97K ﹤0.01%
11,437
+7,772
+212% +$62.8K
CONE
1164
DELISTED
CyrusOne Inc Common Stock
CONE
$97K ﹤0.01%
1,343
+379
+39% +$27K
TAP icon
1165
Molson Coors Class B
TAP
$8.02B
$96K ﹤0.01%
2,828
+1,342
+90% +$53.6K
BTAI icon
1166
BioXcel Therapeutics
BTAI
$24.8M
$95K ﹤0.01%
+113
New +$73.7K
OC icon
1167
Owens Corning
OC
$11B
$95K ﹤0.01%
1,712
+694
+68% +$32.4K
FMS icon
1168
Fresenius Medical Care
FMS
$13.4B
$94K ﹤0.01%
2,190
-3,519
-62% -$139K
LBRDA icon
1169
Liberty Broadband Class A
LBRDA
$4.89B
$94K ﹤0.01%
776
+31
+4% +$3.81K
NMR icon
1170
Nomura Holdings
NMR
$28.3B
$94K ﹤0.01%
21,324
+7,098
+50% +$29.5K
WPM icon
1171
Wheaton Precious Metals
WPM
$49.7B
$94K ﹤0.01%
2,148
-472
-18% -$18.6K
SASR
1172
DELISTED
Sandy Spring Bancorp Inc
SASR
$94K ﹤0.01%
3,804
+3,570
+1,526% +$84.8K
LSXMA
1173
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$94K ﹤0.01%
3,743
-479
-11% -$11.7K
EDIT icon
1174
Editas Medicine
EDIT
$399M
$92K ﹤0.01%
3,183
+1,256
+65% +$32.8K
ERIC icon
1175
Ericsson
ERIC
$32.1B
$91K ﹤0.01%
9,826
-29,342
-75% -$255K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.